Kevin Robert Lind - CEO, Director at Longboard Pharmaceuticals, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
CEO, Director
Stock Symbol
LBPH on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Kevin Robert Lind since 11/23/2023

Holdings reported by Kevin Robert Lind for Longboard Pharmaceuticals, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 364K $1.14M $3.12 Nov 13, 2024 Direct
Stock Option (Right to Buy) 255K Nov 13, 2024 Direct Common Stock
Retention Restricted Stock Units 22K Oct 25, 2024 Direct Voting Common Stock

Transactions reported by Kevin Robert Lind for Longboard Pharmaceuticals, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.